Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no serious side effects in a clinical trial. The anchors explored the push to develop and execute a game plan to distribute vaccines in the U.S.
They also discussed whether now's the time to buy pharmaceutical stocks, plus what to make of this month's retail stock surge heading into the holiday shopping season.
Also in focus: More prominent business leaders including Blackstone CEO Stephen Schwarzman calling on President Trump to accept the election results and begin the transition.